Showing results (211-220 of 887) with videos related to

Sort By:
Pageof 89
Renal Failure|August 25, 2006
The renal safety profile of fluvastatin: results of a pooled analysisHallvard Holdaas, Christoph Wanner, Claudia Abletshauser, et al.
BMC Medical Research Methodology|June 7, 2011
Understanding competing risks: a simulation point of viewArthur Allignol, Martin Schumacher, Christoph Wanner, et al.
Nephron|July 18, 2015
Randomized, Double-Blind, Placebo-Controlled, Withdrawal Study of Colestilan after Dose Titration in Chronic Kidney Disease Dialysis Patients with HyperphosphatemiaJoachim Hertel, Francesco Locatelli, Goce Spasovski, et al.
BMC Medical Genetics|July 20, 2016
Case report of a 45-year old female Fabry disease patient carrying two alpha-galactosidase A gene mutation allelesDaniel Oder, Dorothee Vergho, Georg Ertl, et al.
Journal of Nephrology|May 22, 2007
Phosphatemia is related to chromosomal aberrations of parathyroid glands in patients with hyperparathyroidismJerzy Chudek, Anetta Nagy, Franciszek Kokot, et al.
Journal of the American Society of Nephrology : JASN|April 10, 2009
Combining GFR and albuminuria to classify CKD improves prediction of ESRDStein I Hallan, Eberhard Ritz, Stian Lydersen, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|June 22, 2013
Effects of paricalcitol on calcium and phosphate metabolism and markers of bone health in patients with diabetic nephropathy: results of the VITAL studyDaniel W Coyne, Dennis L Andress, Michael J Amdahl, et al.
American Journal of Physiology. Renal Physiology|March 7, 2002
Retinoid receptor-specific agonists alleviate experimental glomerulonephritisIngo Lehrke, Matthias Schaier, Kerstin Schade, et al.
Clinical Chemistry|March 13, 2010
Serum creatinine, cystatin C, and beta-trace protein in diagnostic staging and predicting progression of primary nondiabetic chronic kidney diseaseKatharina-Susanne Spanaus, Barbara Kollerits, Eberhard Ritz, et al.
Kidney International|June 12, 2009
Changes in adiponectin and the risk of sudden death, stroke, myocardial infarction, and mortality in hemodialysis patientsChristiane Drechsler, Vera Krane, Karl Winkler, et al.
Pageof 89